Clinical Commander

All dossiers
cardio.hypertensive-emergency.maoi-tyramine-crisis.v1

MAOI–tyramine hypertensive crisis ("cheese effect" — severe occipital headache + HTN crisis + tachycardia + diaphoresis after MAOI + tyramine-rich food or sympathomimetic exposure)

cardiologyacuteadultacuteinpatienttransitionoutpatient

Phase E variant of cardio.hypertensive-emergency.core.v1 — narrowed to MAOI-tyramine "cheese reaction" HTN crisis. Inherits HTN-emergency framework + workup arc from parent; specializes for toxidrome-aware pharmacology: PHENTOLAMINE 5 mg IV q5-15 min titrate (cornerstone — alpha-blocker reverses NE surge); nicardipine IV alternative; AVOID β-blocker monotherapy (unopposed alpha vasoconstriction analogous to pheochromocytoma + cocaine teaching); AVOID meperidine (FDA boxed warning — hyperthermic + hypertensive crisis in MAOI); AVOID sympathomimetics (lifetime: pseudoephedrine, phenylephrine, ephedra, OTC cold meds); AVOID SSRI/SNRI/tramadol/dextromethorphan during MAOI + 14-d washout (5-wk for fluoxetine — serotonin syndrome risk). Acute presentation: severe occipital headache + HTN crisis + tachy + diaphoresis within 30 min – 2 h of tyramine-rich food (aged cheese, cured meats, fava beans, soy sauce, draft beer, fermented foods) OR sympathomimetic medication. Long-term: lifetime tyramine-restricted diet education + medication interaction list + MedicAlert bracelet + psychiatry follow-up + pharmacy MTM. Consider switching to MAOI-B selective transdermal selegiline 6 mg/24h (minimal tyramine risk) or alternative antidepressant class with appropriate washout if recurrent reactions. Manifest pointer reuses cardio.hypertensive-emergency.core.v1 manifest. Design-brief pointer reuses parent (MAOI-tyramine-specific differences documented inline). Status INTEGRATED until terminology + RxNav-validated drug codes are reconciled. Authored 2026-05-15 by shard-06-cardio-acute as part of HTN emergency Phase E variant batch (wave 12).

Entry points (3)

  • history
    Irreversible MAOI (phenelzine, tranylcypromine, isocarboxazid, selegiline transdermal high-dose) + tyramine-rich food (aged cheese, cured meats, fava beans, soy sauce, draft beer, fermented foods) OR sympathomimetic medication (decongestant, ephedra, OTC cold med) within 30 min – 2 h (Wimbiscus Cleve Clin J Med 2010 PMID 21048054; Shulman J Clin Psychiatry 2003 PMID 14728101)
    irreversible_maoi_with_recent_tyramine_or_sympathomimetic_exposure
  • symptom
    Severe occipital headache + SBP ≥180/DBP ≥120 + diaphoresis + tachycardia + photophobia within 30 min – 2 h of MAOI + tyramine/sympathomimetic exposure — classic "cheese reaction"
    severe_occipital_headache_with_HTN_crisis
  • symptom
    Patient on irreversible MAOI receiving meperidine, SSRI, SNRI, tramadol, or dextromethorphan — drug-drug interaction with potential for tyramine-like surge or serotonin syndrome overlap
    maoi_meperidine_or_ssri_interaction

Required inputs (12)

  • agerequired
    demographic • used at CONTEXT
    Older patients on MAOI for treatment-resistant depression more likely; education-failure risk drives dietary lapses
  • sbprequired
    vital • used at RED_FLAGS
    Defines crisis threshold; drives titration of phentolamine IV
  • dbprequired
    vital • used at RED_FLAGS
    Component of MAP; DBP >120 supports crisis criterion + alpha-overdrive severity
  • heart_raterequired
    vital • used at RED_FLAGS
    Reflex tachycardia from NE surge + risk of demand ischemia; HR >120 plus HTN drives BP target faster
  • temperaturerequired
    vital • used at RED_FLAGS
    Hyperthermia uncommon in tyramine reactions but possible if serotonin syndrome overlap (MAOI + SSRI/meperidine) → drives differentiation
  • maoi_medication_historyrequired
    history • used at CONTEXT
    Confirms etiology — irreversible MAOI (phenelzine 15 mg/d, tranylcypromine 30-60 mg/d, isocarboxazid, selegiline transdermal 9-12 mg/24h); reversible MAO-A inhibitor (moclobemide) lower risk; selegiline 6 mg/24h transdermal selective MAO-B has minimal tyramine risk
  • dietary_or_sympathomimetic_trigger_historyrequired
    history • used at CONTEXT
    Confirms trigger — aged cheese, cured meats, fava beans, soy sauce, draft/unpasteurized beer, fermented soy, sauerkraut, OR sympathomimetic medication (pseudoephedrine, phenylephrine, ephedra, amphetamines)
  • headache_quality_assessmentrequired
    symptom • used at INITIAL_WORKUP
    Classic cheese-reaction headache: severe, occipital/throbbing, distinct from migraine; concurrent photophobia + N/V common
  • ecg_12_leadrequired
    imaging • used at INITIAL_WORKUP
    Demand ischemia from severe HTN + tachycardia; QTc baseline; baseline for MAOI-related cardiotoxicity assessment
  • troponinrequired
    lab • used at INITIAL_WORKUP
    Demand ischemia rule-out (NE surge can drive Type 2 MI in elderly with CAD)
  • creatininerequired
    lab • used at INITIAL_WORKUP
    eGFR drives drug dosing for phentolamine + nicardipine; baseline for renal injury assessment
  • neurologic_examrequired
    symptom • used at INITIAL_WORKUP
    Focal neurologic deficit suggests ICH (cheese reactions can cause ICH per case reports); exclude with CT head

12-phase flow (10)

  1. 1FRAME
    MAOI–tyramine crisis = irreversible MAO-A/B inhibition + dietary tyramine (aged cheese, cured meats, etc.) OR sympathomimetic medication → tyramine-driven NE flood from sympathetic terminals → severe HTN crisis with severe occipital headache + tachy + diaphoresis within 30 min – 2 h. Pharmacology pivot: PHENTOLAMINE 5 mg IV q5-15 min titrate (alpha-blocker, cornerstone) OR nicardipine IV (autoregulation-aware alternative); AVOID β-blocker monotherapy (unopposed alpha vasoconstriction worsens HTN); AVOID meperidine (can trigger hyperthermic + serotonin reactions in MAOI); SSRI 14-d washout required before/after irreversible MAOI.
    inputs: sbp, dbp, heart_rate, maoi_medication_history, dietary_or_sympathomimetic_trigger_history
    advance: MAOI-tyramine etiology confirmed by history (med + trigger) + clinical features (occipital headache + HTN crisis)
  2. 2ENTRY
    Recognize cheese-reaction toxidrome (severe occipital headache + HTN crisis + tachy + diaphoresis after MAOI + tyramine/sympathomimetic exposure); IV access + cardiac monitor + immediate phentolamine IV bolus
    inputs: age, sbp, temperature
    advance: phentolamine IV ready + ECG done + neuro exam done
  3. 3CONTEXT
    MAOI medication details (which agent, dose, duration); trigger details (specific food/drink, timing of intake, OR sympathomimetic medication); concomitant medications (SSRI, SNRI, tramadol, meperidine, dextromethorphan, decongestants, OTC cold meds, supplements like ephedra, St John's wort); prior tyramine reactions; comorbidities (depression, treatment-resistant depression, refractory bulimia); medication adherence + patient education history
    inputs: age, maoi_medication_history
    advance: comprehensive med rec + trigger identified + interaction screen done
  4. 4RED_FLAGS
    ICH (cheese reactions can cause ICH — case reports of fatal ICH per Wimbiscus 2010); aortic dissection (severe HTN risk factor); MI (NE surge demand ischemia in elderly with CAD); pulmonary edema (acute LV strain); concurrent serotonin syndrome (MAOI + SSRI/meperidine overlap — clonus + hyperthermia + autonomic features); hyperthermia >40°C (suggests serotonin syndrome overlap)
    inputs: sbp, temperature, headache_quality_assessment, neurologic_exam
    actions: htn_emergency
    advance: RED flags screened + life-threats addressed + ICH/dissection/MI/serotonin-syndrome differentiated
  5. 5INITIAL_WORKUP
    ECG (QTc, ischemia, demand strain); troponin (q3-6h × 2 if chest pain or elderly with CAD); CBC + BMP + Mg + lactate; CT head non-con (exclude ICH given severe headache + HTN); CTA chest if dissection concern (back pain, BP differential, pulse deficit); UA for myoglobin if rhabdo; CXR (acute pulmonary edema)
    inputs: ecg_12_lead, troponin, creatinine, neurologic_exam
    actions: panel.cardiac, panel.renal
    advance: workup documented + ICH/dissection/MI/serotonin-syndrome ruled in/out
  6. 6BRANCHING_WORKUP
    If ICH → AHA/ASA 2022 ICH pathway + nicardipine target SBP 130-140; if dissection → CTA + emergency CT surgery; if MI → cardiology + ACS pathway (avoid β-blocker monotherapy); if serotonin syndrome overlap → cyproheptadine + STOP serotonergic agents + route to serotonin-syndrome engine
    advance: syndrome-specific pathway activated if needed
  7. 7TREATMENT
    STEP 1 — Phentolamine 5 mg IV bolus q5-15 min titrate to SBP <160 within 1-2 h (cornerstone — alpha-blocker reverses NE surge); typical total 5-20 mg cumulative. STEP 2 — Nicardipine IV 5 mg/h titrate to max 15 mg/h as alternative or adjunct (autoregulation-aware, useful if phentolamine unavailable or insufficient). STEP 3 — IV fluids (modest crystalloid; avoid overload). STEP 4 — Antiemetic for N/V (metoclopramide caution — extrapyramidal; ondansetron generally OK in tyramine crisis but caution in serotonin overlap). STEP 5 — Pain control (acetaminophen for headache; AVOID meperidine; opioids generally OK if non-meperidine). STEP 6 — If tachycardia persists after phentolamine + BP control, can add esmolol or labetalol cautiously AFTER alpha-blockade (similar logic to pheochromocytoma — alpha first then beta). AVOID β-blocker monotherapy (unopposed alpha worsens HTN; classic teaching from pheochromocytoma + cocaine extends to tyramine crisis). AVOID meperidine (can cause severe hyperthermic + hypertensive reactions in MAOI patients per FDA boxed warning). AVOID nitroprusside (cyanide accumulation if prolonged use + autoregulation issues).
    inputs: sbp, dbp, heart_rate
    advance: phentolamine titrated + BP at target SBP <160 + headache improving + no new neuro deficit
  8. 8DISPOSITION
    ICU / step-down for q15 min BP + telemetry minimum 12-24 h (BP can rebound; concurrent organ damage rule-out); admit minimum 24 h for observation + dietary/medication education + safer-alternative regimen consideration
    advance: monitored bed assigned + 24-h observation plan
  9. 9MONITORING
    Continuous ECG + telemetry; q15-30 min BP; serial troponin q3-6h × 2 if elderly or CAD; serial neuro exam q2h × 12 h; pain score; UOP
    inputs: sbp, heart_rate
    actions: panel.cardiac
    advance: BP at target + no organ damage + headache resolved + dietary/medication education completed
  10. 10FOLLOWUP
    COMPREHENSIVE TYRAMINE-RESTRICTED DIET EDUCATION (handout + dietitian consult; high-tyramine foods to AVOID: aged cheeses, cured meats, fava beans, soy sauce, draft beer, sauerkraut, fermented soy, miso, tempeh, marmite/vegemite, tap beer; safe-in-moderation: pasteurized cheese, fresh meat, processed cheese); MEDICATION INTERACTION LIST education (AVOID sympathomimetics — pseudoephedrine, phenylephrine, ephedra, OTC cold meds, decongestants; AVOID meperidine — FDA boxed warning; AVOID SSRI/SNRI/tramadol/dextromethorphan during MAOI + 14-d washout); psychiatry consultation re: continuing MAOI vs alternative (consider switch to MAOI-B selective transdermal selegiline if low-dose tolerated, OR switch to other antidepressant class with appropriate washout); if MAOI required to continue, dietitian referral + medication card carried + family education + MedicAlert bracelet; outpatient PCP + psychiatry follow-up within 1-2 weeks
    advance: dietary education completed + medication card issued + psychiatry follow-up booked + safer regimen considered